SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040472
Filing Date
2023-11-13
Accepted
2023-11-13 16:00:58
Documents
50
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 913253
2 ex31-1.htm EX-31.1 12695
3 ex31-2.htm EX-31.2 13096
4 ex32-1.htm EX-32.1 11254
5 pipe_001.jpg GRAPHIC 32215
  Complete submission text file 0001493152-23-040472.txt   4130189

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pcsa-20230930.xsd EX-101.SCH 30192
7 XBRL CALCULATION FILE pcsa-20230930_cal.xml EX-101.CAL 37043
8 XBRL DEFINITION FILE pcsa-20230930_def.xml EX-101.DEF 117668
9 XBRL LABEL FILE pcsa-20230930_lab.xml EX-101.LAB 300847
10 XBRL PRESENTATION FILE pcsa-20230930_pre.xml EX-101.PRE 233048
44 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 476815
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 231398398
SIC: 2834 Pharmaceutical Preparations